Transcription regulation by biomolecular condensates

G Pei, H Lyons, P Li, BR Sabari - Nature Reviews Molecular Cell …, 2024 - nature.com
Biomolecular condensates regulate transcription by dynamically compartmentalizing the
transcription machinery. Classic models of transcription regulation focus on the recruitment …

Regulation of HOX gene expression in AML

I Khan, MA Amin, EA Eklund, AL Gartel - Blood cancer journal, 2024 - nature.com
As key developmental regulators, HOX cluster genes have varied and context-specific roles
in normal and malignant hematopoiesis. A complex interaction of transcription factors …

NPM1‐mutated acute myeloid leukemia: New pathogenetic and therapeutic insights and open questions

B Falini - American journal of hematology, 2023 - Wiley Online Library
The nucleophosmin (NPM1) gene encodes for a multifunctional chaperone protein that is
localized in the nucleolus but continuously shuttles between the nucleus and cytoplasm …

Condensate-Promoting ENL Mutation Drives Tumorigenesis In Vivo Through Dynamic Regulation of Histone Modifications and Gene Expression

Y Liu, Q Li, L Song, C Gong, S Tang… - Cancer …, 2024 - aacrjournals.org
Gain-of-function mutations in the histone acetylation “reader” eleven-nineteen-leukemia
(ENL), found in acute myeloid leukemia (AML) and Wilms tumor, are known to drive …

Phase-separated nuclear bodies of nucleoporin fusions promote condensation of MLL1/CRM1 and rearrangement of 3D genome structure

M Oka, M Otani, Y Miyamoto, R Oshima, J Adachi… - Cell Reports, 2023 - cell.com
NUP98 and NUP214 form chimeric fusion proteins that assemble into phase-separated
nuclear bodies containing CRM1, a nuclear export receptor. However, these nuclear bodies' …

Criteria for Diagnosis and Molecular Monitoring of NPM1-Mutated AML

B Falini, R Dillon - Blood cancer discovery, 2024 - aacrjournals.org
NPM1-mutated acute myeloid leukemia (AML) represents the largest molecular subgroup of
adult AML. NPM1-mutated AML is recognizable by molecular techniques and …

An overview of targeted therapies in acute myeloid leukemia

S Turkalj, FA Radtke, P Vyas - Hemasphere, 2023 - journals.lww.com
Acute myeloid leukemia (AML) is the most aggressive adult leukemia, characterized by
clonal differentiation arrest of progenitor or precursor hematopoietic cells. Intense preclinical …

Nucleophosmin 1 promotes mucosal immunity by supporting mitochondrial oxidative phosphorylation and ILC3 activity

R Zhao, J Yang, Y Zhai, H Zhang, Y Zhou, L Hong… - Nature …, 2024 - nature.com
Abstract Nucleophosmin 1 (NPM1) is commonly mutated in myelodysplastic syndrome
(MDS) and acute myeloid leukemia. Concurrent inflammatory bowel diseases (IBD) and …

Nucleophosmin plays a role in repairing DNA damage and is a target for cancer treatment

KR Sekhar, ML Freeman - Cancer Research, 2023 - aacrjournals.org
Nucleophosmin (NPM1) is frequently mutated in acute myeloid leukemia, and NPM1
expression is elevated in several cancer types. NPM1 is a multifunctional oligomeric protein …

[HTML][HTML] Therapeutic targeting in pediatric acute myeloid leukemia with aberrant HOX/MEIS1 expression

KL Juul-Dam, NN Shukla, TM Cooper… - European journal of …, 2023 - Elsevier
Despite advances in the clinical management of childhood acute myeloid leukemia (AML)
during the last decades, outcome remains fatal in approximately one third of patients …